Curative Ventures

TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing

Proceeds will support clinical development of lead program TC-210 and [...]

March 21st, 2018|

BOSTON, Feb. 17, 2014 /PRNewswire/ -- MPM Capital and Atlas Venture announced today [...]

February 17th, 2014|

Curative Ventures
info@curativeventures.com

Address
3963 Maple Avenue, Suite 390
Dallas, TX 75219